Protocol Complexity and Patient Enrollment Intensify Challenges in Oncology Clinical Trials, According to Tufts Center for the Study of Drug Development
May 04, 2021 09:00 ET
|
Tufts Center for the Study of Drug Development
BOSTON, May 04, 2021 (GLOBE NEWSWIRE) -- Increasing complexity of clinical trials targeting cancer—including use of more sophisticated scientific designs, larger global scope, and greater focus on...
Curium Announces Filing of a Generic Version of DaTscanᵀᴹ (Ioflupane I 123 Injection) in the U.S.
May 04, 2021 02:30 ET
|
Curium
St. Louis, MO, May 04, 2021 (GLOBE NEWSWIRE) -- Curium announced today that it submitted an abbreviated new drug application for a generic version of DaTscan (Ioflupane I 123 Injection) with the...
PAVmed to Hold Business Update Conference Call on May 17, 2021
May 03, 2021 09:30 ET
|
PAVmed Inc.
Company conference call and webcast at 4:30 PM EDT NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated,...
Beard Management Inc. Advances from Application Acceptance to Filing Phase in the Premarket Tobacco Product Application Process
April 27, 2021 09:30 ET
|
Beard Management Inc.
AUSTIN, Texas, April 27, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Beard Management Inc., a leading global nicotine-based e-liquid company, announces today that its U.S. Food and Drug...
BriaCell CEO Gives Corporate Overview, Plans for Future in Audio Interview with SmallCapVoice.com
April 21, 2021 08:00 ET
|
Briacell Therapeutics Corp.
AUSTIN, Texas, April 21, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Bill Williams, M.D., President and CEO of BriaCell Therapeutics...
Buchanan, Luria, Mace, Sherrill, and Boyle Introduce FDA Modernization Act to End Mandatory Animal Testing, Lower Drug Prices
April 20, 2021 11:15 ET
|
Animal Wellness Action
Washington, D.C., April 20, 2021 (GLOBE NEWSWIRE) -- Today, Animal Wellness Action, the Center for a Humane Economy, the Michelson Center for Public Policy, and other affiliated organizations...
Blackbriar Regulatory Services, LLC Partners with Beard Management Inc.
April 13, 2021 09:30 ET
|
Blackbriar Regulatory Services
RICHMOND, Va., April 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Blackbriar Regulatory Services (BRS), a firm specializing in helping small to mid-sized domestic and international companies...
vTv Therapeutics Receives FDA Breakthrough Therapy Designation for TTP399 for the Treatment of Type 1 Diabetes
April 13, 2021 07:30 ET
|
vTv Therapeutics Inc.
HIGH POINT, N.C., April 13, 2021 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT) a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for...
Allarity Therapeutics Submits Premarket Approval Application to U.S. FDA for DRP® Companion Diagnostic for Dovitinib
April 02, 2021 07:00 ET
|
Allarity Therapeutics A/S
- Submission precedes expected NDA filing for dovitinib in 2021 - Premarket Approval will allow U.S. marketing of DRP-Dovitinib as companion diagnostic to dovitinib Press release ...
Starton Therapeutics Completes Pre-IND Meeting with FDA: Clearing Path to Phase 1 Clinical Study for STAR-LLD Continuous Infusion
March 22, 2021 08:30 ET
|
Starton Therapeutics, Inc.
PARAMUS, N.J., March 22, 2021 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton” or the “Company”), a clinical stage biotechnology company with a continuous delivery platform of approved drugs...